Big Pharma Vendetta Against Known Cancer Cure
🍏 Laetrile: How the Medical Mafia Buried a Cheap, Natural Cancer Remedy 💀
As science vindicates these therapies, we’re left with one damning question: How many lives were lost to protect a lie? ♠️♥️♣️♦️

🌿 Ancient Wisdom: A 2,000-Year-Old Cancer Remedy
Laetrile (aka amygdalin or “Vitamin B17”) is the most famous of the nitrilosides – a class of natural compounds found abundantly in apricot kernels, bitter almonds, and over 1,200 other seeds and plants. But don’t take my word for it – let’s dive into the history of laetrile, why the FDA calls this “quackery” while approving synthetic drugs (like 5-FU chemotherapy) using the identical cyanide-release mechanism, the buried Sloan Kettering research, and how Big Pharma turned a nutrient into a felony.
The medicinal use of amygdalin-rich seeds spans civilizations and millennia. Ancient Chinese physicians documented apricot kernel preparations for tumors in the Shen Nung Pen Ts’ao Ching, while Greek and Roman texts, including those of Galen and Pliny the Elder, extolled bitter almonds (containing laetrile) for abnormal growths. This therapeutic thread persisted through medieval Arabic medicine, later revived by modern researchers like Dr. Krebs, who isolated laetrile. Yet the most compelling validation comes not from scrolls or labs, but from living people: the Hunza of northern Pakistan.

🏔️ Hunza: The Apricot Kingdom
Here was nature’s controlled experiment: a population thriving on amygdalin-rich foods, immune to a disease ravaging industrialized nations. The Hunza didn’t just use apricot seeds; they revered them. Their traditional diet, coupled with glacial water high in trace minerals, created a synergistic defense against malignancy. While Western medicine dismissed this as “anecdotal,” their reality mocked our cancer epidemics.
The tragic epilogue? As processed foods infiltrated Hunza in recent decades, cancer rates emerged, precisely when kernel consumption declined. Their story mirrors broader historical patterns: cultures employing amygdalin-bearing plants (Egyptian bitter almonds, medieval European millet) consistently showed lower tumor incidence. Science now confirms what Hunza embodied: nitrilosides aren’t just medicine, they’re a missing nutrient.

According to thousands of patients, pioneering doctors like Dr. John Richardson, and anthropological evidence from cancer-free cultures like the Hunza, this nitriloside mechanism may represent one of nature’s most potent anticancer strategies. From Shen Nung’s herbalists to Hunza elders grinding seeds at dawn, the message is identical: nature already solved this. Our arrogance called it “folk medicine”—until genomics proved them right.
🔬 Nature’s Targeted Therapy
Cancer cells’ metabolic addiction to glycolysis (the so-called Warburg effect) creates their fatal vulnerability to laetrile’s targeted attack, while normal cells remain protected by their robust detoxification systems. Contemporary research now confirms what empirical observation long suggested: amygdalin selectively sabotages cancer cells’ energy production by disrupting mitochondrial function. Modern oncology is only beginning to comprehend the sophisticated intelligence built into this ancient therapeutic approach.

⚖️ The Great Suppression
The FDA’s war on laetrile reached its peak with the prosecution of Jason Vale, an alternative health advocate and competitive arm-wrestler who sold apricot kernels. Despite numerous testimonials from cancer patients who benefited from his products, Vale was targeted in an undercover sting operation and sentenced to 63 months in prison – a punishment more severe than many violent criminals receive. We interviewed Jason for our groundbreaking docu-series “The Quest for the Cures,” and his case highlights the extreme measures taken to suppress access to natural cancer treatments. TTAC awarded Jason a lifetime achievement award in 2019, and he continued advocating for health freedom until his death in 2021.

🔍 The Sloan Kettering Scandal: How They Buried the Truth

The scandal deepened when a 1977 MSKCC press release declared laetrile “ineffective,” despite their own unpublished data proving otherwise. This wasn’t science; it was institutional fraud to protect the cancer industry. As Moss later revealed: “The issue wasn’t whether laetrile worked… but that it worked too cheaply.” The exact center that today charges $500,000+ for cancer therapies once buried a treatment that cost pennies.
🌍 Laetrile Today: Banned but Not Forgotten
Thanks for reading! This post is public, so please help us save lives and share it.
Modern research is finally catching up to ancient wisdom. Cutting-edge studies in genomic medicine and cancer metabolism are validating what physicians from Shen Nung to Krebs long asserted—that natural compounds can selectively target malignancies without poisoning the body. The metabolic theory of cancer, once ridiculed, now dominates prestigious journals. Yet the medical establishment, having spent decades and millions suppressing laetrile, faces an inconvenient truth: They were wrong. And worse—they knew it.

The laetrile saga exposes medicine’s original sin: a system that protects profits over patients. When a safe, inexpensive therapy shows promise, why does the response involve raids, prison sentences, and character assassination rather than rigorous study? The answer lies in the cold calculus of power. As economist Milton Friedman warned, “Nothing is so permanent as a temporary government program,” and the war on alternative cancer therapies has become a permanent fixture of our medical-industrial complex. With the cancer industry now worth $200 billion annually, the incentives to suppress unpatentable cures aren’t just strong, they’re overwhelming.
But truth has a way of resurfacing. The same institutions that once mocked laetrile now invest billions in synthetic versions of its mechanism—cyanide-releasing prodrugs and “targeted metabolic therapies” that mimic what apricot kernels offered for free. The hypocrisy would be laughable if lives weren’t at stake.
Here’s the reality they don’t want you to grasp:
- We’ve known about metabolic cancer treatments for millennia—we just buried the evidence.
- The “war on cancer” hasn’t failed—it’s been misdirected to protect a lucrative status quo.
- Every patient who recovers at clinics like Oasis of Hope is a living indictment of our broken system.
The fight isn’t just about laetrile—it’s about whether medicine serves healing or hegemony. As genomic science vindicates these ancient therapies, we’re left with one damning question: How many lives were lost to protect a lie?
The truth was here all along. The question is: Will we finally listen?

Join over 1.25 million TTAC Substack Readers and Subscribers! By becoming a paid subscriber, you can support our work.


Responses